September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
Latebreakers: States undecided on AMP
May 21st 2007A report from the HHS Office of the Inspector General (OIG) has found that most states have not decided whether to use average manufacturer price (AMP) data for Medicaid drug reimbursement due to concerns over the availability and quality of AMP data.
Flushing out bowel disorders: New therapies emerge for both IBS and IBD
May 21st 2007The differences between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are discussed along with emerging treatments for both conditions. The recent withdrawal of tegaserod (Zelnorm) for the treatment of IBS-c has left many searching for new therapies.
Study: Tobacco marketing increases teen smoking
May 14th 2007A new study, published in the Archives of Pediatrics and Adolescent Medicine, concludes that the more cigarette marketing teens are exposed to in retail stores, the more likely they are to smoke, and that restricting these retail marketing practices would reduce smoking among teens.
FDA issues alert for True Man and Energy Max products
May 14th 2007The FDA is advising consumers not to purchase or use True Man and Energy Max products promoted and sold as dietary supplements throughout the U.S. Both products—touted as sexual enhancement aids and treatments for erectile dysfunction (ED)—are illegal products that contain potentially harmful, undeclared ingredients.
Fatal error sparks debate over punitive measures
May 7th 2007The use of intravenous (IV) syringes for non-IV applications such as enteral feedings poses many risks, especially for the pediatric and neonatal population which has a majority of their oral and enteral doses provided through a gastric tube. The Baxa Corporation recently announced the launch of a new educational campaign to make healthcare providers aware of these problems and offer solutions.